Trump Executive Order on Medicare Drug Price Negotiations Explained

Key Components of the Executive Order

• 🎯 The executive order aims to align Medicare drug prices with what hospitals pay, preventing markups.
• 🏥 It also seeks to ensure drugs cost the same regardless of where they are administered, such as outpatient clinics or doctor's offices.
• 💰 A provision targets broker fee disclosure, requiring employee benefit brokers to reveal payments from PBMs they recommend to employer clients.

Medicare Negotiation and the Inflation Reduction Act

• 📜 The order instructs HHS Secretary Kennedy to work with Congress to equalize eligibility for Medicare negotiation for pills and biologics.
• ⚖️ This addresses the "pill penalty" from the 2022 Inflation Reduction Act, which allows Medicare to negotiate prices for small molecules after 9 years and large molecules after 13 years.
• 🤝 While Congress must enact laws, President Trump's backing is seen as a significant win for the industry.

Timeline and Spending Considerations

• ❓ White House officials are reportedly agnostic on the final timeline for negotiation eligibility, with potential for both small and large molecules to be set at 9 years, aligning with industry desires.
• 📈 A key consideration is ensuring any policy changes do not increase Medicare spending, necessitating negotiation with the industry on concessions.